Novozymes A/S logo

Novozymes A/S

NVZMY | OTC
Chart Builder DCF Calculator
$69.21
+$0.14 (+0.21%)
Nov 2, 2026, 3:00 PM ET · Market open
+0.21%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026
52.6
+5.1 pts
Fundamentals Average
Market Sentiment Bullish
Moat Wide
Sector Rank #156/390 (Top 40%)

Key Statistics

Market Data

Market Cap $32.27B
1D Range
68.85 69.79
52W Range
52.81 71.93

Valuation (TTM)

PE 43.52
PB 2.53
EV/EBITDA 17.97

Valuation (NTM)

Forward PE 3.48
Forward PEG -2.07
Price Target $0.00
Loading financial charts...

Profile

Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Its operational footprint spans across Europe, the...

Employees 11,641
IPO Date Jan 20, 2010
Fiscal Year January - December

Latest News

FUL or NVZMY: Which Is the Better Value Stock Right Now?

2 months ago · zacks.com

FUL or NVZMY: Which Is the Better Value Stock Right Now?
Novozymes A/S (NVZMY) Q2 2026 Earnings Call Transcript

2 months ago · seekingalpha.com

Novozymes A/S (NVZMY) Q2 2026 Earnings Call Transcript
FUL vs. NVZMY: Which Stock Is the Better Value Option?

3 months ago · zacks.com

FUL vs. NVZMY: Which Stock Is the Better Value Option?

Earnings

Next Earnings
Nov 5, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.